Date |
Inspection Type |
Inspection ID |
Inspection Result |
|
Dec 4, 2024 |
Monitoring |
2024-I-LIRO-111727
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
416.11(c)(1) |
The Licensee must prepare a health care plan on forms furnished by the Office. Such plan must protect and promote the health of children. The health care plan must be on site, followed by all caregivers and available upon demand by a parent or the Office. In those instances in which the program will administer medications, the health care plan must also be approved by the program's health care consultant unless the only medications to be administered are: |
Corrected |
416.11(f)(16) |
Prescription medication labels must include the following information or be available through the licensed authorized prescriber on the form provided by the Office or equivalent form: |
Corrected |
416.11(f)(21) |
In the case of medication that needs to be given on an ongoing, long-term basis, the authorization and consent forms for children under the age of 5 years of age must be reauthorized at least once every six months. Any changes in the medication authorization related to dosage, time or frequency of administration shall require a program to obtain new instructions written by the licensed authorized prescriber. All other changes to the original medication authorization require a change in the prescription. |
Corrected |
|
Sep 23, 2024 |
Monitoring |
2024-I-LIRO-096065
|
No violations cited for this Inspection |
|
May 20, 2024 |
Annual Unannounced |
2024-I-LIRO-004525
|
No violations cited for this Inspection |
|
Dec 26, 2023 |
Application - Renewal |
2023-I-LIRO-049181
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
416.5(aa) |
Pursuant to New York Public Health Law Section 2500-h, the program must comply with the anaphylaxis policy jointly issued by the Office and the New York State Department of Health and any amendments thereto. The program must notify the parent of any child in care of the anaphylaxis policy when the child is enrolled and annually thereafter. Notification shall include contact information for parents to engage further with the program to learn more about individualized aspects of the anaphylaxis policy. |
Corrected |
|
Jul 10, 2023 |
Monitoring |
2023-I-LIRO-035887
|
No violations cited for this Inspection |
|